NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
ID: 349828Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/349828

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-242.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the NCI Research Specialist (Laboratory-based Scientist) Award (R50), aimed at supporting exceptional scientists engaged in NCI-funded cancer research. This grant is designed for non-tenure track laboratory-based scientists who wish to continue their research careers within existing NCI-funded programs without becoming independent investigators, thereby ensuring stability in the biomedical research community. The award provides salary support and travel costs for a project period not exceeding five years, with applications due by 5:00 PM local time on November 3, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-242-Full-Announcement.html
    PAR-23-242.html
    The National Cancer Institute (NCI) invites applications for the Research Specialist Award (R50), targeted at laboratory-based scientists engaged in NCI-funded cancer research. The award aims to support exceptional scientists who wish to continue their research careers without becoming independent investigators, ensuring stability within the biomedical research community. The application process emphasizes the necessity for a Unit Director, an NCI-funded Program Director with at least one year of funding remaining, who must support the Research Specialist. Eligible applicants include various higher education institutions and organizations; however, foreign entities are excluded. The R50 award provides salary support and travel costs, with a project period not exceeding five years. Applications are due by 5:00 PM local time on specified dates, and adherence to application guidelines is strictly enforced. The selection will involve a peer review process assessing scientific merit, innovation, and investigator qualifications. Successful applicants will receive a Notice of Award, which will outline terms, including data management and sharing obligations. The initiative reflects the NCI's commitment to fostering talent in cancer research while providing necessary resources for research continuity.
    Similar Opportunities
    NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NCI Research Specialist (Core-based Scientist) Award (R50), a federal grant aimed at supporting laboratory-based scientists involved in cancer research. This funding opportunity is designed to provide salary support and promote stable career paths for exceptional researchers who contribute significantly to NCI-funded projects but do not serve as independent investigators. The initiative emphasizes the importance of collaborative scientific support in advancing cancer research and aims to foster a sustainable research workforce, particularly among institutions serving underrepresented groups. Applications are open from October 2, 2023, with awards expected as early as November 2023, and interested parties can find more information and submit inquiries via grantsinfo@nih.gov. The project duration can extend up to five years, with funding covering the Research Specialist's salary and limited travel costs.
    NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Research Specialist (Clinician Scientist) Award (R50), a federal grant aimed at supporting clinician scientists involved in NCI-funded clinical trials. This award is designed to provide salary support and autonomy for exceptional clinician scientists who will not serve as principal investigators but will lead in the development and implementation of national clinical trials and participate in scientific committees. The R50 Award is crucial for ensuring career stability in cancer research, allowing candidates to apply for new, renewal, or resubmission grants over a funding period of up to five years. Applications open on October 4, 2024, and interested parties can find more information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Outstanding Investigator Award (R35 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NCI Outstanding Investigator Award (R35), aimed at providing long-term support for exceptional cancer research projects. This grant opportunity is designed for accomplished investigators with a proven track record in cancer research, allowing them to pursue innovative and high-risk projects that could lead to significant advancements in the field. The award offers up to $600,000 in direct costs per year for a maximum duration of seven years, with applications due by November 7, 2024. Interested applicants can find more information and contact details at the provided link: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-045.html.
    The NCI Transition Career Development Award (K22 Independent Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Transition Career Development Award (K22), a federal grant aimed at supporting researchers transitioning from mentored, non-independent positions to their first independent tenure-track faculty roles in cancer research. This grant provides funding for up to three years, covering both salary and research development expenses, with the goal of enhancing the applicant's potential to secure independent NIH grants and fostering a diverse pool of capable scientists in the biomedical field. Eligible applicants include various institutions and organizations, particularly those serving underrepresented groups, and must adhere to detailed application guidelines. Interested parties can find more information and apply before the closing date of November 12, 2025, by visiting the NIH grants website or contacting NIH Grants Information at grantsinfo@nih.gov.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows into independent faculty positions in cancer research. This grant program is designed for researchers with doctoral degrees who require minimal additional mentored training, providing up to two years of support during the K99 phase followed by up to three years of independent research funding in the R00 phase. The initiative underscores NIH's commitment to strengthening the workforce in cancer research, particularly in areas such as cancer control and prevention, while ensuring that applicants present a comprehensive career development plan and mentorship strategy. Applications will open on January 14, 2024, with potential awards beginning in February 2024; interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows to independent faculty positions. This program is specifically designed for researchers with clinical or research doctoral degrees who require minimal additional mentored training and are proposing to lead independent clinical trials or studies. The award consists of two phases: the K99 phase provides up to $100,000 annually for two years of mentored research, followed by the R00 phase, which offers up to $249,000 per year for three years of independent research. Interested applicants must adhere to detailed submission guidelines and can find more information at the provided NIH link. The application deadline is October 14, 2026, and inquiries can be directed to grantsinfo@nih.gov.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is offering the K99/R00 Pathway to Independence Award aimed at supporting early-stage postdoctoral researchers transitioning to independent research positions. This funding opportunity is designed for postdoctoral fellows with research or clinical doctoral degrees, focusing on studies involving human participants that meet the NIH definitions of clinical trials and basic research, particularly in cancer control, prevention, and data sciences. The program consists of a two-phase structure: the K99 phase provides up to two years of mentored support, while the R00 phase offers up to three years of independent research funding, contingent on progress and securing a faculty position. Interested applicants must adhere to strict guidelines and institutional nominations, with key deadlines approaching in January 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-288.html.
    The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00), aimed at supporting outstanding graduate students transitioning to independent cancer research careers. This grant provides a maximum of six years of funding, divided into one to two years for dissertation research and up to four years for postdoctoral training, specifically designed to enhance the capabilities of cancer research in the U.S. Eligible applicants include a diverse range of institutions, and the application process opened on October 17, 2023, with a submission deadline of November 19, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-042.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for the NCI Research Specialist (Clinician Scientist) Award (R50), which will not allow clinical trials. This grant aims to support clinician scientists involved in NCI-funded clinical trials research by fostering stable research career opportunities and encouraging leadership in the development and implementation of clinical trials. The award is particularly significant as it seeks to enhance participation in NCI clinical trials networks, ensuring a diverse representation of institutions in the application process. The Notice of Funding Opportunity (NOFO) is expected to be published in late summer 2024, with a single application due date of November 5, 2024, and an estimated award date of May 30, 2025. Interested applicants should prepare their submissions accordingly, as applications are limited to four per institution.
    NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Mentored Research Scientist Development Award to Promote Diversity (K01), a federal grant aimed at enhancing diversity within the cancer research workforce. This funding opportunity supports individuals from underrepresented backgrounds in biomedical and clinical sciences by providing salary and research support for a period of 3 to 5 years under the mentorship of experienced researchers, specifically for projects that do not involve leading independent clinical trials. The initiative is crucial for addressing disparities in cancer incidence and mortality rates among underserved populations, fostering a diverse pool of research talent, and promoting innovative solutions to complex health challenges. Interested applicants must submit their proposals by November 12, 2024, and can find additional information and application guidelines at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.